Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,575 | 643 | 98.6% |
| Education | $134.50 | 7 | 1.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,512 | 69 | $0 (2024) |
| PFIZER INC. | $862.86 | 75 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $847.02 | 68 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $742.94 | 46 | $0 (2022) |
| Allergan, Inc. | $692.18 | 71 | $0 (2020) |
| Lilly USA, LLC | $679.36 | 45 | $0 (2024) |
| Amgen Inc. | $661.36 | 39 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $490.00 | 31 | $0 (2023) |
| ABBVIE INC. | $416.21 | 25 | $0 (2024) |
| Novo Nordisk Inc | $341.25 | 25 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $199.93 | 10 | PFIZER INC. ($79.00) |
| 2023 | $718.80 | 44 | PFIZER INC. ($189.37) |
| 2022 | $834.76 | 53 | Lilly USA, LLC ($178.04) |
| 2021 | $1,135 | 75 | AbbVie Inc. ($225.40) |
| 2020 | $1,134 | 75 | AstraZeneca Pharmaceuticals LP ($279.64) |
| 2019 | $1,615 | 117 | Amgen Inc. ($244.15) |
| 2018 | $2,109 | 124 | AstraZeneca Pharmaceuticals LP ($567.95) |
| 2017 | $1,963 | 152 | Janssen Pharmaceuticals, Inc ($358.23) |
All Payment Transactions
650 individual payment records from CMS Open Payments — Page 1 of 26
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/29/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $27.27 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 02/26/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: Diabetes | ||||||
| 02/20/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $20.75 | General |
| Category: NEUROSCIENCE | ||||||
| 02/19/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/16/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $13.53 | General |
| Category: PAIN | ||||||
| 02/14/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $27.73 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/06/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.64 | General |
| Category: DIABETES | ||||||
| 02/01/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $17.99 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/22/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: Diabetes | ||||||
| 01/17/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $22.04 | General |
| Category: PAIN | ||||||
| 12/18/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN, TRULANCE | Food and Beverage | In-kind items and services | $13.28 | General |
| Category: Gastroenterology | ||||||
| 12/04/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $13.99 | General |
| Category: Diabetes | ||||||
| 11/30/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/08/2023 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $17.56 | General |
| Category: VACCINES | ||||||
| 10/26/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $20.41 | General |
| Category: Cardiovascular | ||||||
| 10/25/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $14.39 | General |
| Category: Oncology | ||||||
| 10/19/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $17.70 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/03/2023 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $17.27 | General |
| Category: PAIN | ||||||
| 09/28/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $19.62 | General |
| Category: Cardiovascular | ||||||
| 09/13/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $20.83 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/12/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $16.07 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/11/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: Oncology | ||||||
| 08/30/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $13.99 | General |
| Category: Diabetes | ||||||
| 08/23/2023 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $19.72 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 07/26/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $15.31 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 286 | 474 | $40,893 | $26,125 |
| 2022 | 8 | 281 | 458 | $38,342 | $23,452 |
| 2021 | 5 | 197 | 339 | $30,103 | $18,330 |
| 2020 | 6 | 226 | 381 | $34,350 | $17,716 |
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 70 | 192 | $16,842 | $10,881 | 64.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 49 | 49 | $6,860 | $5,876 | 85.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 38 | 60 | $6,600 | $4,380 | 66.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 50 | 86 | $6,450 | $3,109 | 48.2% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 14 | 20 | $2,700 | $894.12 | 33.1% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 49 | 49 | $1,225 | $833.00 | 68.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 16 | 18 | $216.00 | $151.20 | 70.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 74 | 177 | $15,652 | $9,748 | 62.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 49 | 49 | $6,860 | $5,903 | 86.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 48 | 107 | $8,025 | $4,113 | 51.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 28 | 39 | $4,290 | $2,472 | 57.6% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 38 | 38 | $950.00 | $632.41 | 66.6% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 13 | 13 | $1,456 | $398.30 | 27.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 12 | 13 | $845.00 | $127.04 | 15.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 19 | 22 | $264.00 | $59.22 | 22.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 66 | 141 | $12,336 | $7,367 | 59.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 41 | 41 | $5,740 | $4,885 | 85.1% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 54 | 119 | $8,925 | $4,409 | 49.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 25 | 27 | $2,970 | $1,642 | 55.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 11 | 11 | $132.00 | $27.00 | 20.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 72 | 150 | $13,096 | $6,404 | 48.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 47 | 47 | $6,580 | $5,123 | 77.9% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 64 | 134 | $10,050 | $3,711 | 36.9% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 13 | 16 | $3,040 | $1,745 | 57.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 12 | 12 | $1,320 | $679.74 | 51.5% |
About Dr. Jeffrey Lenz, MD
Dr. Jeffrey Lenz, MD is a Family Medicine healthcare provider based in West Des Moines, Iowa. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1124082706.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jeffrey Lenz, MD has received a total of $9,710 in payments from pharmaceutical and medical device companies, with $199.93 received in 2024. These payments were reported across 650 transactions from 45 companies. The most common payment nature is "Food and Beverage" ($9,575).
As a Medicare-enrolled provider, Lenz has provided services to 990 Medicare beneficiaries, totaling 1,652 services with total Medicare billing of $85,623. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location West Des Moines, IA
- Active Since 04/12/2006
- Last Updated 11/19/2010
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1124082706
Products in Payments
- FARXIGA (Drug) $1,227
- Aimovig (Biological) $479.03
- JARDIANCE (Drug) $462.99
- ENTRESTO (Drug) $437.83
- XARELTO (Drug) $432.13
- UBRELVY (Drug) $411.90
- CHANTIX (Drug) $403.47
- ELIQUIS (Drug) $397.24
- INVOKANA (Drug) $310.81
- XIFAXAN (Drug) $279.13
- TRULICITY (Drug) $219.84
- LINZESS (Drug) $212.94
- MOUNJARO (Drug) $189.08
- Ozempic (Drug) $173.96
- AJOVY (Biological) $167.01
- VIBERZI (Drug) $156.29
- Repatha (Biological) $139.47
- ZENPEP (Drug) $138.00
- TRADJENTA (Drug) $132.64
- BYDUREON (Drug) $121.09
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in West Des Moines
Basil Hassan, Md, MD
Family Medicine — Payments: $17,360
Dawn Schissel, Md, MD
Family Medicine — Payments: $17,086
Dale Grunewald, D.o, D.O
Family Medicine — Payments: $12,944
Malea Jensen, Do, DO
Family Medicine — Payments: $9,418
Majed Barazanji, M.d, M.D
Family Medicine — Payments: $8,911
Jeffrey Schoon, Do, DO
Family Medicine — Payments: $1,041